Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?

Seminars in Cell & Developmental Biology
Mara Mather

Abstract

Many believe that engaging in novel and mentally challenging activities promotes brain health and prevents Alzheimer's disease in later life. However, mental stimulation may also have risks as well as benefits. As neurons release neurotransmitters, they often also release amyloid peptides and tau proteins into the extracellular space. These by-products of neural activity can aggregate into the tau tangle and amyloid plaque signatures of Alzheimer's disease. Over time, more active brain regions accumulate more pathology. Thus, increasing brain activity can have a cost. But the neuromodulator noradrenaline, released during novel and mentally stimulating events, may have some protective effects-as well as some negative effects. Via its inhibitory and excitatory effects on neurons and microglia, noradrenaline sometimes prevents and sometimes accelerates the production and accumulation of amyloid-β and tau in various brain regions. Both α2A- and β-adrenergic receptors influence amyloid-β production and tau hyperphosphorylation. Adrenergic activity also influences clearance of amyloid-β and tau. Furthermore, some findings suggest that Alzheimer's disease increases noradrenergic activity, at least in its early phases. Because older br...Continue Reading

References

Sep 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·R AdolfssonB Winblad
Feb 1, 1992·The American Journal of Psychiatry·N PomaraP A LeWitt
Jan 1, 1990·Progress in Neurobiology·M Erecińska, I A Silver
Feb 1, 1988·The Journal of Clinical Endocrinology and Metabolism·M A RaskindJ B Halter
Apr 1, 1984·Physiological Reviews·G L StilesR J Lefkowitz
Jun 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·D M MannS Toper
Apr 1, 1984·Archives of General Psychiatry·M A RaskindD C Jimerson
Jan 1, 1993·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·M MartinezA Hernanz
Jan 15, 1996·Biological Psychiatry·V ArangoJ J Mann
Jan 1, 1997·The American Journal of Psychiatry·R ElrodM A Raskind
Jan 15, 1999·Pharmacology & Therapeutics·J Wess
Jan 23, 1999·Annals of Neurology·W J HoogendijkD F Swaab
Jan 23, 1999·Journal of Neurophysiology·D A Hoffman, D Johnston
Nov 4, 2000·The Journal of Physiology·D R Seals, M D Esler

❮ Previous
Next ❯

Citations

Jul 25, 2021·International Journal of Molecular Sciences·Paul J Fitzgerald

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

© 2021 Meta ULC. All rights reserved